Tickers

1. Composite Trajectory Verdict

The income statement matters most for assessing RRX's financial performance because the company's high leverage and ongoing debt repayment make profitability and margin expansion the primary drivers of debt capacity and shareholder returns.

Composite Trajectory: Improving

Overall Assessment: In FY2025 versus FY2024, net sales declined 1.6% to $5,934.5M but organic sales grew 0.8% (10-K 2025-12-31, MD&A). Gross margin expanded to 37.4% from 36.3%, operating margin to 11.5% from 10.4%, and net income attributable to Regal Rexnord rose 42% to $279.5M (10-K 2025-12-31, Consolidated Statements of Operations). Operating cash flow surged 63% to $990.8M, aided by $372.5M of receivables securitization (10-K 2025-12-31, Cash Flows). Total debt fell $669M to $4.79B, net debt dropped ~$800M, and shareholders' equity grew 9% to $6.84B (10-K 2025-12-31, Balance Sheet). All three statements show improvement in the latest year, though revenue growth remains modest.

2. Red Flags

• Receivables securitization facility initiated June 2025 sold $372.5M of receivables, boosting operating cash flow by a similar amount and reducing trade receivables from $842.8M to $524.2M; the facility incurred $9.4M in charges (10-K 2025-12-31, Note 6).
• Large near-term debt maturity: $1,124.1M due in 2026 including $1,100M 2026 Senior Notes; the company refinanced $850M via a new term loan in February 2026 (10-K 2025-12-31, Note 7).
• Goodwill impairment risk highlighted for Factory Automation reporting unit; quantitative test used discount rates of 12.5%-13.5% and fair value exceeded carrying value by >10% for only three of five tested units (10-K 2025-12-31, Critical Audit Matter).
• Accumulated other comprehensive loss swung from -$442.7M to -$75.4M due to a $345.4M foreign currency translation gain in 2025 after a -$251.6M loss in 2024, indicating significant equity volatility from FX (10-K 2025-12-31, Consolidated Statements of Comprehensive Income).
• Recurring losses on sale of businesses: $4.5M in 2025, $8.5M in 2024, $87.7M in 2023 (10-K 2025-12-31, Consolidated Statements of Operations).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Overall Assessment: FY2025 net income attributable to Regal Rexnord increased 42% to $279.5M from $196.2M in FY2024, following a FY2023 loss of $57.4M (10-K 2025-12-31, Consolidated Statements of Operations). Diluted EPS rose to $4.20 from $2.94 and -$0.87. Gross margin improved to 37.4% from 36.3% and 33.1%, operating margin to 11.5% from 10.4% and 6.0%. Organic sales grew 0.8% in FY2025 after a divestiture-impacted decline in FY2024 (10-K 2025-12-31, MD&A). Interest expense fell 12.6% to $349.2M, improving interest coverage (operating income/interest) to 1.95x from 1.58x. The effective tax rate held near 20%.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Overall Assessment: Operating cash flow jumped 63% to $990.8M in FY2025 from $609.4M in FY2024, but FY2024 was down 15% from $715.3M in FY2023 (10-K 2025-12-31, Consolidated Statements of Cash Flows). The FY2025 increase was driven largely by $372.5M of cash proceeds from the new receivables securitization facility and higher net income, partially offset by working capital changes (10-K 2025-12-31, MD&A). Free cash flow (CFO minus capex) rose to ~$893M from ~$500M. Capital expenditures declined to $97.7M from $109.5M. The securitization facility represents a one-time working capital benefit that may not recur at the same magnitude.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Overall Assessment: Total debt decreased to $4.79B at 12/31/2025 from $5.46B at 12/31/2024, with the term loan fully repaid ($665M) and revolving facility borrowings reduced (10-K 2025-12-31, Note 7). Cash rose to $521.7M from $393.5M, lowering net debt by roughly $800M. Shareholders' equity grew 9% to $6.84B from $6.26B, driven by net income and a $367.8M other comprehensive income gain (mostly FX translation). The current ratio slipped to 2.1x from 2.3x due to lower current assets (receivables down $318M from securitization) and higher current liabilities. Goodwill and intangibles were stable at $6.6B and $3.4B respectively.

6. Data Gaps

• Quarterly financial statements (10-Qs for Q1-Q3 2025 and Q1-Q2 2026) were listed as provided but their content is not included in the filings text; without them, intra-year trends and the most recent quarter cannot be assessed.
• Full FY2023 balance sheet (only FY2025 and FY2024 are presented) limits leverage trend analysis prior to 2024.
• Segment-level operating expense breakdowns (e.g., R&D, SG&A) are not separately disclosed in the filings; only segment income from operations and adjusted expenses are provided.
• The impact of the 2025 Credit Agreement (effective Nov 2025) on covenant calculations and future interest expense is not fully quantified beyond the 2025 Term Facility borrowing in Feb 2026.
• Organic sales growth for FY2024 (excluding divestitures) is not explicitly reconciled in the provided text.